Robert L. Jilka - Concepedia

Author

Robert L. Jilka

University of Arkansas for Medical Sciences

Also Known As

R L Jilka, ROBERT L. JILKA, Robert Jilka, Robert L Jilka, Robert L. Jilka

103

Publications

16.4K

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Central Arkansas Veterans Healthcare System University of Kansas Medical Center Kansas City VA Medical Center Geriatric Research Education and Clinical Center

About

Robert L. Jilka is an author at University of Arkansas for Medical Sciences specializing in medicine, osteoporosis, and bone metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	39	6.2K
2	Health Sciences	21	21	3.9K
3	Natural Sciences	5	5	149
4	Engineering	3	3	1.4K
5	Public Health	1	1	146

Robert L. Jilka

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6 Robert L. Jilka, Giao Hangoc, Giuseppe Girasole, Science	1992	1.5K
Matrix-embedded cells control osteoclast formation Jinhu Xiong, Melda Onal, Robert L. Jilka, Nature Medicine Tissue EngineeringMechanobiologyEngineeringMatrix-embedded Cells ControlBone Morphogenic Protein	2011	1.3K
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone Robert L. Jilka, Robert S. Weinstein, Teresita Bellido, Journal of Clinical Investigation	1999	1K
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids Maria Almeida, Li Han, Marta Martín-Millán, Journal of Biological Chemistry	2007	689
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines Robert L. Jilka, Robert S. Weinstein, Teresita Bellido, Journal of Bone and Mineral Research	1998	573
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. Beata Lecka‐Czernik, Igor Gubrij, Elena J. Moerman, PubMed Molecular BiologyAdipokinesOsteoporosisAscorbic AcidMetabolic Syndrome	1999	467
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation Arshad Ali, Robert S. Weinstein, Scott Stewart, Endocrinology SclerostinBone FormationOsteoporosisOrthopaedic SurgeryOxidative Stress	2005	444
Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor-γ2 Ligands on Adipocyte Versus Osteoblast Differentiation Beata Lecka‐Czernik, Elena J. Moerman, David F. Grant, Endocrinology	2002	436
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR?2 Beata Lecka‐Czernik, Igor Gubrij, Elena J. Moerman, Journal of Cellular Biochemistry SclerostinAdipokinesOsteoporosisAscorbic AcidBone Morphogenic Protein	1999	405
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes Charles A. O’Brien, Lilian I. Plotkin, Carlo Galli, PLoS ONE SclerostinOrthopaedic SurgeryOsteoporosisBone Morphogenic ProteinParathyroid Hormone	2008	379

Page 1